It is a developed drug for the treatment of obesity and type 2 diabetes, based on the GLP/GIP dual receptor agonist Tirzepatide, which can achieve triple (GLP-1/GIP/GCG) agonist effect by hybridizing glucagon related structures
As such, a larger study with broader eligibility criteria would augment generalizability of the study outcomes
Like the medications used by humans, the experimental pet treatments are designed to regulate appetite by mimicking natural hormones that slow digestion and signal fullness
And if necessary, medical options like ondansetron, which your prescriber can provide for severe cases
Effect of exenatide on cholecystokinin-induced gallbladder emptying in fasting healthy subjects
When people on TikTok say they're "microdosing" semaglutide at 0.25 mg per week, they are, in many cases, simply taking the FDA-approved starting dose of Ozempic